Health
NIH awards Kellogg Lab nearly $3 million to continue research on molecular mechanisms that control cell growth, size
Doug Kellogg, professor of molecular, cell, and developmental biology at UC Santa Cruz, has been awarded $2.95 million from the National Institutes of Health (NIH) to study control of cell growth and size in normal cells—and how it goes wrong in cancer.
Doug Kellogg, professor of molecular, cell, and developmental biology at UC Santa Cruz, has been awarded $2.95 million from the National Institutes of Health (NIH) to study control of cell growth and size in normal cells—and how it goes wrong in cancer.
The five-year grant—formally named the Maximizing Investigators Research Award—will fund multiple projects in Kellogg’s lab. In Kellogg’s words, “severe defects in cell size are a nearly universal feature of cancer cells, and these defects have been used by pathologists to detect cancer cells for over 100 years. But the molecular basis for the defects have remained largely unknown. Discovery of the mechanisms that control cell growth and size could identify new targets for anti-cancer drugs.”
The new funding, which started February 1, will allow the Kellogg Lab to continue the work that the Science Division honored with its 2018-19 Outstanding Faculty Award—the division’s highest honor for faculty achievement, recognizing combined excellence in research, teaching, and service.